Acasti Pharma (ACST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACST | SLGL | MGX | ||
| Company | Acasti Pharma | Sol-Gel Technologies Ltd | Metagenomi Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.38 | 71.98 | 1.1900 | ||
| High | 3.45 | 74.69 | 1.2299 | ||
| Low | 3.20 | 69.54 | 1.1900 | ||
| Latest | 3.37 | 74.46 | 1.2000 | ||
| Change | -0.03 | +4.10 | +0.0200 | ||
| % Change | -0.88% | +5.83% | +1.69% | ||
| Volume | 27,800 | 17,500 | 190,400 | ||
| 20-Day Average Volume | 34,930 | 43,990 | 172,525 | ||
| Previous Close | 3.40 | 70.36 | 1.1800 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.24 | 74.02 | 1.2800 | ||
| 20-Day Raw Stochastic | 72.29% | 61.39% | 24.14% | ||
| 20-Day Relative Strength | 58.39 | 50.94 | 40.15 | ||
| Weighted Alpha | +24.36 | +344.55 | -34.07 | ||
| Today's Opinion | 40% Buy | 56% Buy | 100% Sell | ||
| Previous Opinion | 40% Buy | 24% Buy | 100% Sell | ||
| Last Month's Opinion | 8% Sell | 24% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.20% since 10/18/24 | -1.12% since 06/11/26 | -4.00% since 06/11/26 | ||
| Low | 3.12 on 10/21/24 | 69.54 on 06/18/26 | 1.1300 on 06/17/26 | ||
| High | 3.60 on 10/23/24 | 76.88 on 06/12/26 | 1.2800 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +10.13% since 09/25/24 | +8.94% since 05/18/26 | -5.51% since 05/18/26 | ||
| Low | 2.77 on 10/01/24 | 62.50 on 05/19/26 | 1.1300 on 06/17/26 | ||
| High | 3.60 on 10/23/24 | 81.53 on 05/29/26 | 1.4200 on 05/27/26 | ||
| 3-Month | |||||
| %Chg | +19.08% since 07/25/24 | -1.17% since 03/18/26 | -16.67% since 03/18/26 | ||
| Low | 2.13 on 09/12/24 | 61.92 on 03/23/26 | 1.1300 on 06/17/26 | ||
| High | 3.60 on 10/23/24 | 93.53 on 03/24/26 | 1.5500 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | +15.08% since 04/25/24 | +74.18% since 12/18/25 | -27.71% since 12/18/25 | ||
| Low | 2.13 on 09/12/24 | 38.91 on 12/19/25 | 1.1300 on 06/17/26 | ||
| High | 3.60 on 10/23/24 | 97.97 on 03/03/26 | 1.8700 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 31,676 | 209,225 | 45,176 | ||
| Shares Outstanding, K | 9,399 | 2,810 | 37,647 | ||
| Annual Sales | 0 | 19,390,000 | 25,210,000 | ||
| Annual Net Income | -12,850,000 | -6,130,000 | -87,870,000 | ||
| Last Quarter Sales | 0 | 110,000 | 1,250,000 | ||
| Last Quarter Net Income | -2,620,000 | -3,730,000 | -23,060,000 | ||
| 60-Month Beta | 1.52 | 1.13 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.24 on 08/09/24 | -1.31 on 05/28/26 | -0.61 on 05/11/26 | ||
| Earnings Date | 11/11/24 | 08/21/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||